Inflammation in acne scarring: a comparison of the responses in lesions from patients prone and not prone to scar
- PMID: 14746619
- DOI: 10.1111/j.1365-2133.2004.05749.x
Inflammation in acne scarring: a comparison of the responses in lesions from patients prone and not prone to scar
Abstract
Background: Many patients with inflammatory acne suffer from significant scarring, which is disfiguring and difficult to treat. A cell-mediated immune response is considered to be involved in the pathogenesis of acne, although the extent of this response has been found to differ among patients.
Objective: To assess whether there were differences in the cell-mediated immune responses at different time points in inflamed lesion development and resolution in patients who were prone (S patients) and those with the same degree of inflamed acne who were not prone (NS patients) to develop scarring.
Methods: Cellular and vascular markers were investigated using standard immunohistochemical techniques on biopsies of inflamed lesions of known duration, i.e. < 6 h (n = 14), 24 h (n = 14), 48 h (n = 10), 72 h (n = 10) and 6-7 days (n = 11) from the backs of acne patients.
Results: In early lesions from NS patients there was a large influx of CD4+ T cells, macrophages and Langerhans cells with a high number of cells expressing HLA-DR. Also there was significant angiogenesis and vascular adhesion molecule expression. Cell recruitment peaked in 48 h lesions, after which leucocyte numbers decreased and vascular activity returned to normal. Of the T cells, only 50% were memory/effector (CD45RO+) and naive (CD45RA+) cells, while the remainder were unclassified (CD45RO-, CD45RA-). In early lesions from S patients, CD4+ T cell numbers were smaller, although a high proportion were skin homing memory/effector cells. Langerhans cell numbers and cellular HLA-DR expression were low, while numbers of macrophages, blood vessels and vascular adhesion molecules were high. In resolving lesions angiogenesis remained high, with a further influx of macrophages and skin homing memory/effector cells and increased cellular HLA-DR expression.
Conclusions: The cellular infiltrate was large and active with a greater nonspecific response (few memory T cells) in early lesions of NS patients, which subsided in resolution. In contrast, a predominantly specific immune response was present in S patients, which was initially smaller and ineffective, but was increased and activated in resolving lesions. Such excessive inflammation in healing tissue is conducive to scarring and suggests that the use of topical anti-inflammatory treatments would be appropriate for these patients.
Similar articles
-
Immunohistochemical investigation of evolving inflammation in lesions of acne vulgaris.Exp Dermatol. 1998 Aug;7(4):191-7. doi: 10.1111/j.1600-0625.1998.tb00323.x. Exp Dermatol. 1998. PMID: 9758417
-
Inflammatory events are involved in acne lesion initiation.J Invest Dermatol. 2003 Jul;121(1):20-7. doi: 10.1046/j.1523-1747.2003.12321.x. J Invest Dermatol. 2003. PMID: 12839559
-
The role of inflammation in the pathogenesis of acne and acne scarring.Semin Cutan Med Surg. 2005 Jun;24(2):79-83. doi: 10.1016/j.sder.2005.03.004. Semin Cutan Med Surg. 2005. PMID: 16092795 Review.
-
Atrophic scar formation in patients with acne involves long-acting immune responses with plasma cells and alteration of sebaceous glands.Br J Dermatol. 2018 Oct;179(4):906-917. doi: 10.1111/bjd.16680. Epub 2018 Aug 16. Br J Dermatol. 2018. PMID: 29663317
-
Current therapeutic approach to acne scars.Acta Dermatovenerol Croat. 2010;18(3):171-5. Acta Dermatovenerol Croat. 2010. PMID: 20887698 Review.
Cited by
-
Truncal Acne and Scarring: A Comprehensive Review of Current Medical and Cosmetic Approaches to Treatment and Patient Management.Am J Clin Dermatol. 2023 Mar;24(2):199-223. doi: 10.1007/s40257-022-00746-4. Epub 2022 Dec 20. Am J Clin Dermatol. 2023. PMID: 36539678 Review.
-
Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study.Dermatol Ther (Heidelb). 2023 Dec;13(12):3085-3096. doi: 10.1007/s13555-023-01042-7. Epub 2023 Oct 15. Dermatol Ther (Heidelb). 2023. PMID: 37838987 Free PMC article.
-
How People with Facial Acne Scars are Perceived in Society: an Online Survey.Dermatol Ther (Heidelb). 2016 Jun;6(2):207-18. doi: 10.1007/s13555-016-0113-x. Epub 2016 Apr 18. Dermatol Ther (Heidelb). 2016. PMID: 27090421 Free PMC article.
-
Fillers for the improvement in acne scars.Clin Cosmet Investig Dermatol. 2015 Sep 29;8:493-9. doi: 10.2147/CCID.S86478. eCollection 2015. Clin Cosmet Investig Dermatol. 2015. PMID: 26491364 Free PMC article. Review.
-
Prevalence and risk factors of acne scars in patients with acne vulgaris.Skin Res Technol. 2023 Jun;29(6):e13386. doi: 10.1111/srt.13386. Skin Res Technol. 2023. PMID: 37357642 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous